<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>PID Clinical Reference | NICE CKS Quick Guide</title>
  <style>
    :root {
      --primary: #1a73e8;
      --secondary: #f8f9fa;
      --accent: #d4edda;
      --danger: #f8d7da;
      --text: #202124;
      --border: #dadce0;
      --success: #28a745;
    }

    * {
      margin: 0;
      padding: 0;
      box-sizing: border-box;
    }

    body {
      font-family: 'Segoe UI', Roboto, 'Helvetica Neue', sans-serif;
      line-height: 1.6;
      color: var(--text);
      background-color: #f5f7fa;
    }

    .container {
      max-width: 900px;
      margin: 20px auto;
      padding: 20px;
      background: white;
      border-radius: 12px;
      box-shadow: 0 4px 15px rgba(0, 0, 0, 0.1);
    }

    header {
      text-align: center;
      margin-bottom: 25px;
      border-bottom: 2px solid var(--primary);
      padding-bottom: 10px;
    }

    h1 {
      font-size: 1.8rem;
      color: var(--primary);
      font-weight: 600;
    }

    .subtitle {
      color: #5f6368;
      font-size: 1rem;
    }

    .section {
      margin-bottom: 24px;
      padding: 16px;
      border-left: 4px solid var(--primary);
      background-color: var(--secondary);
      border-radius: 0 8px 8px 0;
    }

    .section h2 {
      font-size: 1.3rem;
      color: var(--primary);
      margin-bottom: 10px;
    }

    .section ul {
      list-style-type: none;
    }

    .section ul li::before {
      content: "‚Ä¢";
      color: var(--primary);
      font-weight: bold;
      display: inline-block;
      width: 1em;
      margin-left: -1em;
    }

    .highlight {
      background-color: var(--accent);
      padding: 12px;
      border-radius: 8px;
      font-size: 0.95rem;
      border: 1px solid #c3e6cb;
    }

    .caution {
      background-color: var(--danger);
      padding: 12px;
      border-radius: 8px;
      font-size: 0.95rem;
      border: 1px solid #f5c6cb;
      color: #721c24;
    }

    .table-container {
      overflow-x: auto;
      margin: 12px 0;
    }

    table {
      width: 100%;
      border-collapse: collapse;
      font-size: 0.95rem;
    }

    th, td {
      padding: 10px;
      text-align: left;
      border-bottom: 1px solid var(--border);
    }

    th {
      background-color: var(--primary);
      color: white;
    }

    tr:nth-child(even) {
      background-color: #f2f6fc;
    }

    footer {
      text-align: center;
      margin-top: 30px;
      font-size: 0.85rem;
      color: #5f6368;
      border-top: 1px solid var(--border);
      padding-top: 15px;
    }

    @media (max-width: 600px) {
      .container {
        padding: 15px;
        margin: 10px;
      }
      h1 {
        font-size: 1.5rem;
      }
    }
  </style>
</head>
<body>
  <div class="container">
    <header>
      <h1>Pelvic Inflammatory Disease (PID)</h1>
      <p class="subtitle">Quick Reference Algorithm for Primary Care ‚Äî Based on NICE CKS (June 2024)</p>
    </header>

    <!-- Suspect PID -->
    <div class="section">
      <h2>üîç Suspect PID If</h2>
      <ul>
        <li>Sexually active female, age ‚â•13 years</li>
        <li><strong>Lower abdominal pain</strong> + <strong>cervical motion tenderness</strong></li>
        <li>Plus at least one of:
          <ul style="margin-left: 15px;">
            <li>Adnexal tenderness</li>
            <li>Abnormal vaginal discharge</li>
            <li>Elevated CRP/ESR</li>
          </ul>
        </li>
        <li><strong>Supportive signs:</strong> Fever, dyspareunia, intermenstrual bleeding, dysuria</li>
        <li><strong>Risk factors:</strong> New/multiple partners, recent IUD insertion (<20 days), STI history</li>
      </ul>
    </div>

    <!-- Differential Diagnosis -->
    <div class="section">
      <h2>‚ö†Ô∏è Rule Out</h2>
      <ul>
        <li>Ectopic pregnancy <strong>(always test for pregnancy)</strong></li>
        <li>Ovarian torsion</li>
        <li>Appendicitis</li>
        <li>UTI</li>
        <li>Endometriosis</li>
      </ul>
    </div>

    <!-- First-Line Treatment -->
    <div class="section">
      <h2>üíä First-Line Outpatient Antibiotics</h2>
      <div class="highlight">
        <strong>Ceftriaxone</strong> 1g IM (single dose)<br>
        <strong>Doxycycline</strong> 100mg PO twice daily √ó 14 days<br>
        <strong>Metronidazole</strong> 400mg PO twice daily √ó 14 days
      </div>
    </div>

    <!-- Alternatives -->
    <div class="section">
      <h2>üîÑ Alternative Regimens</h2>
      <p><strong>If penicillin/cephalosporin allergy:</strong></p>
      <ul>
        <li><strong>Azithromycin</strong> 2g single dose OR 500mg OD √ó 3 days</li>
        <li><strong>+ Doxycycline</strong> 100mg BD √ó 14 days</li>
        <li><strong>+ Metronidazole</strong> 400mg BD √ó 14 days</li>
      </ul>
      <p style="margin-top: 10px;"><strong>Fluoroquinolones (caution ‚Äì MHRA 2023):</strong></p>
      <ul>
        <li><strong>Moxifloxacin</strong> 400mg OD √ó 14 days (monotherapy)</li>
        <li><strong>Ofloxacin</strong> 400mg BD + <strong>Metronidazole</strong> 400mg BD √ó 14 days</li>
        <li><strong>Levofloxacin</strong> 500mg OD √ó 14 days + Metronidazole if needed</li>
      </ul>
      <div class="caution">
        ‚ö†Ô∏è Avoid fluoroquinolones in tendon disorders, CNS disease, or prolonged QT. Reserve due to safety concerns.
      </div>
    </div>

    <!-- When to Refer -->
    <div class="section">
      <h2>üè• Refer Immediately If</h2>
      <ul>
        <li>Severe illness, vomiting, high fever</li>
        <li>Pregnancy suspected or confirmed</li>
        <li>No improvement in 72 hours</li>
        <li>Unable to exclude surgical emergency</li>
        <li>Tubo-ovarian abscess on imaging</li>
        <li>Unable to tolerate oral therapy</li>
      </ul>
    </div>

    <!-- Follow-Up & Advice -->
    <div class="section">
      <h2>üìã Follow-Up & Patient Advice</h2>
      <ul>
        <li>Reassess in 48‚Äì72 hours</li>
        <li>Sexual abstinence until 7 days after treatment starts and partners treated</li>
        <li>Test for STIs: Chlamydia, gonorrhoea, HIV, syphilis</li>
        <li>Treat all partners from past 6 weeks (asymptomatic too)</li>
      </ul>
    </div>

    <!-- Drug Safety Table -->
    <div class="section">
      <h2>üíä Key Drug Warnings (MHRA, 2023)</h2>
      <div class="table-container">
        <table>
          <thead>
            <tr>
              <th>Drug</th>
              <th>Key Warnings</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td><strong>Doxycycline</strong></td>
              <td>Photosensitivity, oesophagitis (take with water), fixed drug eruption</td>
            </tr>
            <tr>
              <td><strong>Metronidazole</strong></td>
              <td>Disulfiram-like reaction with alcohol, metallic taste</td>
            </tr>
            <tr>
              <td><strong>Fluoroquinolones</strong></td>
              <td>Tendon rupture, neuropathy, CNS effects, QT prolongation</td>
            </tr>
            <tr>
              <td><strong>Azithromycin</strong></td>
              <td>Prolonged QT (caution with other QT-prolonging drugs)</td>
            </tr>
          </tbody>
        </table>
      </div>
    </div>

    <!-- Pregnancy & Breastfeeding -->
    <div class="section">
      <h2>ü§∞ Pregnancy & Breastfeeding</h2>
      <ul>
        <li><strong>Avoid:</strong> Doxycycline, fluoroquinolones</li>
        <li><strong>Preferred:</strong> Ceftriaxone + Azithromycin ¬± Metronidazole</li>
        <li><strong>Compatible with breastfeeding:</strong> Azithromycin, metronidazole</li>
      </ul>
    </div>

    <footer>
      <p><strong>Source:</strong> NICE CKS ‚Äì Pelvic Inflammatory Disease (June 2024), BASHH (2019), MHRA Drug Safety Update</p>
      <p>¬© Clarity Informatics Ltd (Agilio Software Primary Care). Used under licence.</p>
    </footer>
  </div>
</body>
</html>